Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Frasers to launch fresh bid for XXL

(Sharecast News) - Mike Ashley's Frasers Group is to make a mandatory offer for Norway's XXL, the retailer confirmed on Tuesday, just weeks after abandoning its pursuit of the sporting goods specialist. An XXL shareholder, late last year Frasers tabled an offer worth 10 Norwegian kroner per share - or NOK 246.36m (£18.01m) in total - to take full control of the business.

It dropped the approach when other large shareholders made it known they would not back the bid.

But on Tuesday, Frasers - the owner of Sports Direct and Jack Wills, among others - confirmed it had taken part in a rights issue XXL launched in January, increasing its stake to 32.9% and so triggering a mandatory offer.

Under Norwegian trading rules, if an investor owns more than a third of the allocated shares, they are obligated to make a bid for the remaining stock.

In brief statements to the London and Oslo Stock Exchanges, Frasers said it would own a total of 32.9% of all shares, and around 40.8% of the voting A shares, upon registration of the new share capital and delivery of the allocated shares.

It therefore would be making a mandatory offer, having crossed the one-third threshold.

It did not provide any further details, other than to confirm a further announcement would be made "in due course".

As at noon GMT, shares in Frasers were up 2% at 646p, while XXL had surged 16% to over NOK 13.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.